Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
13,897,321
-
Share change
-
+264,538
-
Total reported value
-
$100,057,000
-
Price per share
-
$7.20
-
Number of holders
-
25
-
Value change
-
+$1,909,766
-
Number of buys
-
12
-
Number of sells
-
9
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2014
As of 31 Dec 2014,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,897,321 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, Candriam Luxembourg S.C.A., VANGUARD GROUP INC, WALL STREET ASSOCIATES, MASON STREET ADVISORS, LLC, JPMORGAN CHASE & CO, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.